Leukemia Inhibitory Factor Suppresses NKG2D mRNA Expression and Presentation on Human Natural Killer Cells.

Leukemia inhibitory factor (LIF) is a multi-functional cytokine secreted from cells such as lymphocytes and hepatocytes. This study aimed to evaluate the effect of LIF on natural killer group 2 member D (NKG2D) receptors' expression and presentation on natural killer (NK) cells.  For this purpose, peripheral blood mononuclear cells taken from 4 young male healthy blood donors were isolated and the effect of LIF (25 ng/mL) after 12, 24, and 48 hours of incubation, on NKG2D receptors expression and presentation was investigated using flow cytometry and real-time-polymerase chain reaction (PCR). All of the steps of the experiment were performed in duplicate. After periods of 12, 24, and 48 hours, LIF reduced both the expression and presentation of the NKG2D receptor on NK cells. The results suggest that this cytokine has a direct modulating activity on the body's immune response through suppression of NKG2D receptor expression and presentation on NK cells.

[1]  M. Vidal-Jorge,et al.  Molecular mechanisms involved in the immunomodulation induced by LIF in cancer , 2016 .

[2]  V. Baekelandt,et al.  Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis , 2015, Brain, Behavior, and Immunity.

[3]  V. Baekelandt,et al.  Leukemia inhibitory factor shifts the immune balance towards regulatory T cells , 2014, Journal of Neuroimmunology.

[4]  N. Giribabu,et al.  Leukemia Inhibitory Factor: Roles in Embryo Implantation and in Nonhormonal Contraception , 2014, TheScientificWorldJournal.

[5]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[6]  N. Inoue,et al.  The contribution of leukemia inhibitory factor (LIF) for embryo implantation differs among strains of mice. , 2014, Immunobiology.

[7]  Zhen Liu,et al.  LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway , 2014, Oncotarget.

[8]  Yu-Sun Chang,et al.  Role of leukemia inhibitory factor in nasopharyngeal carcinogenesis , 2014, Molecular & cellular oncology.

[9]  N. Nicola,et al.  The role of leukemia inhibitory factor in tubal ectopic pregnancy. , 2013, Placenta.

[10]  H. Reyburn,et al.  Human NKG2D-ligands: cell biology strategies to ensure immune recognition , 2012, Front. Immun..

[11]  Jingwu Z. Zhang,et al.  Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease. , 2011, Immunity.

[12]  Parinya Noisa,et al.  A simple method for production and purification of soluble and biologically active recombinant human leukemia inhibitory factor (hLIF) fusion protein in Escherichia coli. , 2011, Journal of biotechnology.

[13]  T. Kilpatrick,et al.  Therapeutic potential of LIF in multiple sclerosis. , 2010, Trends in molecular medicine.

[14]  Peter Chen,et al.  Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition. , 2010, Cancer research.

[15]  L. Lanier,et al.  TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. , 2010, Neuro-oncology.

[16]  B. Suarez-Alvarez,et al.  NKG2D ligands: key targets of the immune response. , 2008, Trends in immunology.

[17]  A. Aguilar-Lemarroy,et al.  Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions , 2008, BMC Cancer.

[18]  H. Gascan,et al.  Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. , 2007, Blood.

[19]  J. Coligan,et al.  IL-21 Down-Regulates NKG2D/DAP10 Expression on Human NK and CD8+ T Cells1 , 2006, The Journal of Immunology.

[20]  Jing-jing Li,et al.  Effect of leukemia inhibitory factor on embryonic stem cell differentiation: implications for supporting neuronal differentiation , 2006, Acta Pharmacologica Sinica.

[21]  S. Metcalfe.  Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[22]  J. Szepietowski,et al.  Cutaneous Leukemia Inhibitory Factor and Its Potential Role in the Development of Skin Tumors , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[23]  V. Buggiano,et al.  Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. , 2003, Experimental cell research.

[24]  S A Bustin,et al.  Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. , 2002, Journal of molecular endocrinology.

[25]  S. Keshavjee,et al.  Heparin interference with reverse transcriptase polymerase chain reaction of RNA extracted from lungs after ischemia-reperfusion , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[26]  J. Bertherat,et al.  Leukemia inhibitory factor as an intrapituitary regulator of pro-opiomelanocortin gene expression and corticotrope ontogeny. , 1999, European journal of endocrinology.

[27]  J. Copel,et al.  Elevated amniotic fluid levels of leukemia inhibitory factor, interleukin 6, and interleukin 8 in intra-amniotic infection. , 1998, American journal of obstetrics and gynecology.

[28]  J. Heath,et al.  Crystal structure of a cytokine‐binding region of gp130 , 1998, The EMBO journal.

[29]  G. Buirski,et al.  Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides. , 1993, Arthritis and rheumatism.

[30]  T. Willson,et al.  Cross-species comparison of the sequence of the leukaemia inhibitory factor gene and its protein. , 1992, European journal of biochemistry.

[31]  J. Brugge,et al.  Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation , 1991, Molecular and cellular biology.